Literature DB >> 11683910

Circadian activity rhythm in methamphetamine-treated Clock mutant mice.

S Masubuchi1, S Honma, H Abe, W Nakamura, K Honma.   

Abstract

It is well established that the Clock gene is essential for expressing circadian activity rhythms in mammals under constant darkness. The Clock gene product is a positive component of a molecular feedback loop which is assumed to generate the circadian rhythm. On the other hand, chronic treatment of methamphetamine (MAP) induces locomotor activity rhythm in a circadian domain, which is independent of the suprachiasmatic nucleus (SCN) and is driven by a pacemaker outside the SCN. However, it is not known whether the pacemaker outside the SCN possesses a similar molecular mechanism to that in the SCN. Here we show that MAP restores locomotor activity rhythm in arrhythmic homozygous Clock mutant (Clock/Clock) mice under constant darkness. This result indicates that the Clock mutation does not affect the MAP-induced locomotor rhythm.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11683910     DOI: 10.1046/j.0953-816x.2001.01749.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  15 in total

1.  The methamphetamine-sensitive circadian oscillator does not employ canonical clock genes.

Authors:  Jennifer A Mohawk; Matthew L Baer; Michael Menaker
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-09       Impact factor: 11.205

2.  Impaired memory and reduced sensitivity to the circadian period lengthening effects of methamphetamine in mice selected for high methamphetamine consumption.

Authors:  Reid H J Olsen; Charles N Allen; Victor A Derkach; Tamara J Phillips; John K Belknap; Jacob Raber
Journal:  Behav Brain Res       Date:  2013-08-14       Impact factor: 3.332

3.  Period determination in the food-entrainable and methamphetamine-sensitive circadian oscillator(s).

Authors:  Julie S Pendergast; Gisele A Oda; Kevin D Niswender; Shin Yamazaki
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-13       Impact factor: 11.205

4.  The Clock Gene Rev-Erbα Regulates Methamphetamine Actions on Circadian Timekeeping in the Mouse Brain.

Authors:  Nora L Salaberry; Maria Mateo; Jorge Mendoza
Journal:  Mol Neurobiol       Date:  2016-09-01       Impact factor: 5.590

Review 5.  Circadian dysregulation of clock genes: clues to rapid treatments in major depressive disorder.

Authors:  B G Bunney; J Z Li; D M Walsh; R Stein; M P Vawter; P Cartagena; J D Barchas; A F Schatzberg; R M Myers; S J Watson; H Akil; W E Bunney
Journal:  Mol Psychiatry       Date:  2014-11-04       Impact factor: 15.992

Review 6.  Circadian rhythms, the molecular clock, and skeletal muscle.

Authors:  Mellani Lefta; Gretchen Wolff; Karyn A Esser
Journal:  Curr Top Dev Biol       Date:  2011       Impact factor: 4.897

7.  Effects of neonatal methamphetamine and thioperamide exposure on spatial memory retention and circadian activity later in life.

Authors:  Emily Eastwood; Charles N Allen; Jacob Raber
Journal:  Behav Brain Res       Date:  2012-02-11       Impact factor: 3.332

8.  Lithium and genetic inhibition of GSK3beta enhance the effect of methamphetamine on circadian rhythms in the mouse.

Authors:  Jennifer A Mohawk; Manuel Miranda-Anaya; Ozgur Tataroglu; Michael Menaker
Journal:  Behav Pharmacol       Date:  2009-03       Impact factor: 2.293

9.  Chronic methamphetamine uncovers a circadian rhythm in multiple-unit neural activity in the dorsal striatum which is independent of the suprachiasmatic nucleus.

Authors:  Shota Miyazaki; Yu Tahara; Christopher S Colwell; Gene D Block; Wataru Nakamura; Takahiro J Nakamura
Journal:  Neurobiol Sleep Circadian Rhythms       Date:  2021-06-25

10.  Lack of association between prokineticin 2 gene and Japanese methamphetamine dependence.

Authors:  Taro Kishi; Tsuyoshi Kitajima; Tomoko Tsunoka; Takenori Okumura; Kunihiro Kawashima; Tomo Okochi; Yoshio Yamanouchi; Yoko Kinoshita; Hiroshi Ujike; Toshiya Inada; Mitsuhiko Yamada; Naohisa Uchimura; Ichiro Sora; Masaomi Iyo; Norio Ozaki; Nakao Iwata
Journal:  Curr Neuropharmacol       Date:  2011-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.